Cel Sci (CVM) Receivables - Net (2011 - 2021)
Cel Sci (CVM) posted Receivables - Net of $54922.0 for Q4 2021, little changed sequentially from $54922.0 in Q3 2021, and little changed YoY from $54922.0 in Q4 2020.
Cel Sci (CVM) Receivables - Net (2011 - 2021) Analysis & Trends
Cel Sci has reported Receivables - Net for 11 years, with the latest figure at $54922.0 in Q4 2021.
- Quarterly Receivables - Net changed 0.0% year-over-year to $54922.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $54922.0 (changed 0.0% YoY) and the FY2021 annual result came in at $54922.0, changed 0.0% from the prior year.
- Receivables - Net was little changed at $54922.0 in Q4 2021 per CVM's latest filing, from $54922.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $271737.0 in Q2 2017 and troughed at $4252.0 in Q1 2017.
- A 5-year average of $104403.5 and a median of $76904.0 in 2019 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2017 and 2018: Receivables - Net slumped 99.35% in 2017, then jumped 3116.91% in 2018.
- Over 5 years, Receivables - Net stood at $47610.0 in 2017, then soared by 170.45% to $128762.0 in 2018, then declined by 29.29% to $91043.0 in 2019, then sank by 39.67% to $54922.0 in 2020, then changed by 0.0% to $54922.0 in 2021.
- According to Business Quant data, Receivables - Net over the past three periods registered $54922.0, $54922.0, and $54922.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 54,922.00 |
| Dec 31, 2021 | 54,922.00 |
| Sep 30, 2021 | 54,922.00 |
| Sep 30, 2021 | 54,922.00 |
| Jun 30, 2021 | 54,922.00 |
| Jun 30, 2021 | 54,922.00 |
| Mar 31, 2021 | 54,922.00 |
| Mar 31, 2021 | 54,922.00 |
| Dec 31, 2020 | 54,922.00 |
| Dec 31, 2020 | 54,922.00 |
| Sep 30, 2020 | 54,922.00 |
| Sep 30, 2020 | 54,922.00 |
| Jun 30, 2020 | 255,007.00 |
| Jun 30, 2020 | 255,007.00 |
| Mar 31, 2020 | 62,289.00 |
| Mar 31, 2020 | 62,289.00 |
| Dec 31, 2019 | 91,043.00 |
| Dec 31, 2019 | 91,043.00 |
| Sep 30, 2019 | 62,765.00 |
| Sep 30, 2019 | 62,765.00 |